Terms: = Uterine cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
97 results:
1. Deciphering age-specific molecular features in cervical cancer and constructing an angio-immune prognostic model.
Zhao X; Fan X; Lin X; Guo B; Yu Y
Medicine (Baltimore); 2024 Apr; 103(15):e37717. PubMed ID: 38608077
[TBL] [Abstract] [Full Text] [Related]
2. Jagged1 contained in MSC-derived small extracellular vesicles promotes squamous differentiation of cervical cancer by activating NOTCH pathway.
Li W; Zhang X; Gao T; Liu L; Zhang C; Yang H; Xie J; Pan W; Deng DYB; Zhang C; Li T
J Cancer Res Clin Oncol; 2023 Dec; 149(20):18093-18102. PubMed ID: 37994984
[TBL] [Abstract] [Full Text] [Related]
3. MicroRNA‑130a‑3p inhibition suppresses cervical cancer cell progression.
Causin RL; Van Helvoort Lengert A; Gomes INF; De Freitas AJA; Rosa MN; Dos Reis R; Reis RM; Marques MMC
Oncol Rep; 2023 May; 49(5):. PubMed ID: 37052265
[TBL] [Abstract] [Full Text] [Related]
4. HOTAIR knockdown impairs metastasis of cervical cancer cells by down-regulating metastasis-related genes.
Shi L; Zhang D; Han H; Zhang L; Li S; Yang F; He C
J Obstet Gynaecol; 2023 Dec; 43(1):2181060. PubMed ID: 36972141
[TBL] [Abstract] [Full Text] [Related]
5. Bioinformatic and Experimental Analyses Reveal That KIF4A Is a Biomarker of Therapeutic Sensitivity and Predicts Prognosis in Cervical cancer Patients.
Wu J; Li L; Zhong H; Zhang HH; Li J; Zhang HB; Zhao YQ; Xu B; Song QB
Curr Med Sci; 2022 Dec; 42(6):1273-1284. PubMed ID: 36260268
[TBL] [Abstract] [Full Text] [Related]
6. Molecular classification of human papillomavirus-positive cervical cancers based on immune signature enrichment.
Song G; Luo J; Zou S; Lou F; Zhang T; Zhu X; Yang J; Wang X
Front Public Health; 2022; 10():979933. PubMed ID: 36203656
[TBL] [Abstract] [Full Text] [Related]
7. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous Ovarian cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract] [Full Text] [Related]
8. Comprehensive Study of Human FBXW7 Deleterious nsSNP's Functional Inference and Susceptibility to Gynaecological cancer.
Vasuki KA; Christy HJ
Appl Biochem Biotechnol; 2022 Jan; 194(1):407-433. PubMed ID: 34817806
[TBL] [Abstract] [Full Text] [Related]
9. MiR-499b-5p inhibits cervical cancer cell proliferation and induces apoptosis by targeting the notch1 signaling pathway.
Liu HM; Ji F; Lu Y; Chen SY
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6220-6231. PubMed ID: 34730202
[TBL] [Abstract] [Full Text] [Related]
10. MEK inhibition overcomes resistance to EphA2-targeted therapy in uterine cancer.
Wu Y; Huang J; Ivan C; Sun Y; Ma S; Mangala LS; Fellman BM; Urbauer DL; Jennings NB; Ram P; Coleman RL; Hu W; Sood AK
Gynecol Oncol; 2021 Oct; 163(1):181-190. PubMed ID: 34391578
[TBL] [Abstract] [Full Text] [Related]
11. Inhibition of the notch signaling pathway overcomes resistance of cervical cancer cells to paclitaxel through retardation of the epithelial-mesenchymal transition process.
Sun T; Zhang D; Wang Z; Zhao B; Li Y; Sun X; Liu J; Wang X; Sheng J
Environ Toxicol; 2021 Sep; 36(9):1758-1764. PubMed ID: 34048126
[TBL] [Abstract] [Full Text] [Related]
12. Delta-Like Ligand-notch1 Signaling Is Selectively Modulated by HPV16 E6 to Promote Squamous Cell Proliferation and Correlates with Cervical cancer Prognosis.
Khelil M; Griffin H; Bleeker MCG; Steenbergen RDM; Zheng K; Saunders-Wood T; Samuels S; Rotman J; Vos W; van den Akker BE; de Menezes RX; Kenter GG; Doorbar J; Jordanova ES
Cancer Res; 2021 Apr; 81(7):1909-1921. PubMed ID: 33500246
[TBL] [Abstract] [Full Text] [Related]
13. miR‑34c‑5p targets notch1 and suppresses the metastasis and invasion of cervical cancer.
Wei H; Wang X; Niu X; Jiao R; Li X; Wang S
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300051
[TBL] [Abstract] [Full Text] [Related]
14. Mutation profiling of uterine cervical cancer patients treated with definitive radiotherapy.
Yoshimoto Y; Sasaki Y; Murata K; Noda SE; Miyasaka Y; Hamamoto J; Furuya M; Hirato J; Suzuki Y; Ohno T; Tokino T; Oike T; Nakano T
Gynecol Oncol; 2020 Nov; 159(2):546-553. PubMed ID: 32951893
[TBL] [Abstract] [Full Text] [Related]
15. hn1 promotes tumor associated lymphangiogenesis and lymph node metastasis via NF-κB signaling activation in cervical carcinoma.
Chen J; Qiu J; Li F; Jiang X; Sun X; Zheng L; Zhang W; Li H; Wu H; Ouyang Y; Chen X; Lin C; Song L; Zhang Y
Biochem Biophys Res Commun; 2020 Sep; 530(1):87-94. PubMed ID: 32828320
[TBL] [Abstract] [Full Text] [Related]
16. LncRNA ROR promotes proliferation of endometrial cancer cells via regulating notch1 pathway.
Zeng SY; Liu CQ; Zhuang Y; Chen Y; Gu LL; Shi SQ
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):5970-5978. PubMed ID: 32572910
[TBL] [Abstract] [Full Text] [Related]
17. Forskolin promotes vasculogenic mimicry and invasion via Notch‑1‑activated epithelial‑to‑mesenchymal transition in syncytiolization of trophoblast cells in choriocarcinoma.
Xue Y; Sun R; Zheng W; Yang L; An R
Int J Oncol; 2020 May; 56(5):1129-1139. PubMed ID: 32319581
[TBL] [Abstract] [Full Text] [Related]
18. Relevance research between the expression of p16
Huo W; Zhai S; Wang Y; Qiang X; Na R; Gui H; Wu N; Cao Y; Bai H
J Clin Lab Anal; 2020 May; 34(5):e23207. PubMed ID: 31976596
[TBL] [Abstract] [Full Text] [Related]
19. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Bateman NW; Teng PN; Hope E; Hood BL; Oliver J; Ao W; Zhou M; Wang G; Tommarello D; Wilson K; Litzy T; Conrads KA; Hamilton CA; Darcy KM; Casablanca Y; Maxwell GL; Bae-Jump V; Conrads TP
Cancer Med; 2020 Feb; 9(3):1092-1103. PubMed ID: 31808620
[TBL] [Abstract] [Full Text] [Related]
20. Downregulations of miR-449a and miR-145-5p Act as Prognostic Biomarkers for Endometrial cancer.
Wu X; Han Y; Liu F; Ruan L
J Comput Biol; 2020 May; 27(5):834-844. PubMed ID: 31513434
[TBL] [Abstract] [Full Text] [Related]
[Next]
